Technology
Health
Pharmaceutical

Ra Pharmaceuticals

$27.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.22 (0.82%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell RARX and other stocks, options, ETFs, and crypto commission-free!

About

Ra Pharmaceuticals, Inc. Common Stock, also called Ra Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in the development of peptide-based drugs for a variety of therapeutic uses. Read More The company's product include RA101495 SC, which is an injection into the tissue under the skin, for the treatment of paroxysmal nocturnal hemoglobinuria. Ra Pharmaceuticals was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.

Employees
72
Headquarters
Cambridge, Massachusetts
Founded
2008
Market Cap
1.13B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
330.55K
High Today
$27.47
Low Today
$26.45
Open Price
$26.60
Volume
121.31K
52 Week High
$27.68
52 Week Low
$4.78

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2016 IPO
US
North America

News

MarketBeatMar 1

Stock Price, News, & Analysis for Ra Pharmaceuticals

Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system in the United States. The company's peptide chemistry platform enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. Its lead product candidate is RA101495, an injection into the tissue under the skin t...

753
BusinessWireFeb 28

Ra Pharmaceuticals Supports 12th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today joins forces with 30 million healthcare advocates around the world for the 12th Annual Rare Disease Day®, an awareness day dedicated to elevating public understanding of rare diseases and calling attention to the special challenges people living with rare diseases face. “ Despite important scientific advances in the treatment of rare diseases, there remains significant work to be done to help patients and families. At Ra Pharma...

479

Earnings

-$0.68
-$0.61
-$0.54
-$0.47
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.52 per share
Actual
-$0.47 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.